MedPath

Effectiveness of Blue Led to treat Vaginal Candidiasis: randomized controlled trial

Phase 2
Recruiting
Conditions
Pruritus Vulvae
Leukorrhea
C01.150.703.160.190
Registration Number
RBR-3zzqsfh
Lead Sponsor
niversidade Federal do Delta do Parnaíba UFDPAR
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

The research will include women; aged between 18 e 40 years; residing in the Coastal Plain; with a proven medical diagnosis of recurrent vaginal candidiasis; who have steady partners; are not pregnant or in menopause; are not immunocompromised patients or undergoing oncological treatment; are not undergoing use of metronidazole or other medication that may interfere with the vaginal microflora; do not present lesions in the Pap smear; and have good cognitive and verbal conditions, and who agree to participate in the research, after reading, understanding and signing the Free and Consent Form Clarified - TCLE

Exclusion Criteria

Volunteers will be excluded from the research if they have infections of other types; are treated for candidiasis with other modalities at the time of the research; if their partners do not undergo the associated treatment; if they request to withdraw from the research

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Elimination or reduction of Candida albicans infection through photobiomodulation with blue Light Emitting Diode-LED in the treatment of recurrent vaginal candidiasis in menaccal women
Secondary Outcome Measures
NameTimeMethod
Improvement in quality of life, quality of sleep, level of stress, anxiety, depression in volunteers with adequate adherence to treatment
© Copyright 2025. All Rights Reserved by MedPath